Filing Details

Accession Number:
0001209191-20-064953
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-23 09:00:47
Reporting Period:
2020-12-21
Accepted Time:
2020-12-23 09:00:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178253 Scynexis Inc SCYX Pharmaceutical Preparations (2834) 562181648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644071 David Gonzalez Angulo 1 Evertrust Plaza, 13Th Floor
Jersey City NJ 07302-6548
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-21 1,600 $6.25 23,780 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant Acquisiton 2020-12-21 800 $0.00 800 $7.33
Common Stock Common Stock Warrant Acquisiton 2020-12-21 800 $0.00 800 $8.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
800 2020-12-21 2021-12-21 No 4 A Direct
800 2020-12-21 2024-06-21 No 4 A Direct
Footnotes
  1. Reflects the purchase on December 21, 2020 of 1,600 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant).